Go to Sygnis Pharma AG Homepage  

SYGNIS Pharma AG

SYGNIS is a specialty pharma company that pioneers innovative therapies for disorders of the Central Nervous System (CNS), in particular of the brain.

Current Press Release

• 15.12.2011 : SYGNIS Announces Key Results of its Phase II Trial of AX200 in Acute Ischemic Stroke